🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PREdictive Risk Factors of Conversion Into Idiopathic RBD. Italian Study

Recruitingn/aAges 18 Years - anyAllUniversity of Cagliari
NCT05262543 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

REM Sleep Behavior Disorder (RBD) is a REM sleep parasomnia first described in 1986 and characterized by the loss of physiological muscle atonia typical of REM sleep and by the presence of abnormal, sometimes violent, motor activity often related to dream content The observed motor behaviors are often associated to vivid dreams, characterized by an aggressive-defensive content, even if pleasant dreams have been described, resulting in non-violent behaviors. Diagnosis of RBD requires video-polysomnographic recording (vPSG) at a Sleep Center, essential to identify and quantify the complete or intermittent loss of physiological muscle atonia during REM sleep (REM sleep without atonia, RSWA) and record any related motor behaviors. The exact prevalence of RBD in the general population is not known and it seems underrated, but is estimated to be 0.3-1.15%. RBD is defined as idiopathic or isola

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age: major of 18 years old * iRBD diagnosis, according to diagnostic criteria of the ICSD second and third edition Exclusion Criteria: * Impossibility to provide or withdraw informed consent and inability to read, write and understand the purpose and modality of the study.
💊

What it tests

  • Not listed
📍

Where

2 sites
IRCCS Auxologico Piancavallo
Oggebbio, Italy
Centro Interdipartimentale di Medicina del Sonno, Università degli studi di Cagliari
Cagliari, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy